Natixis Advisors L.P. Has $14.60 Million Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Natixis Advisors L.P. grew its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 91.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 188,876 shares of the company's stock after purchasing an additional 90,296 shares during the quarter. Natixis Advisors L.P.'s holdings in GE HealthCare Technologies were worth $14,603,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the business. First Command Advisory Services Inc. boosted its stake in shares of GE HealthCare Technologies by 36,900.0% in the 3rd quarter. First Command Advisory Services Inc. now owns 370 shares of the company's stock valued at $25,000 after buying an additional 369 shares during the period. OFI Invest Asset Management acquired a new position in GE HealthCare Technologies during the 3rd quarter worth approximately $26,000. ORG Partners LLC increased its position in shares of GE HealthCare Technologies by 174.2% in the 3rd quarter. ORG Partners LLC now owns 425 shares of the company's stock valued at $29,000 after purchasing an additional 270 shares during the last quarter. Fortitude Family Office LLC acquired a new stake in shares of GE HealthCare Technologies in the 4th quarter valued at $29,000. Finally, Turtle Creek Wealth Advisors LLC purchased a new stake in shares of GE HealthCare Technologies during the 4th quarter worth $30,000. Institutional investors and hedge funds own 82.06% of the company's stock.

GE HealthCare Technologies Stock Performance

NASDAQ:GEHC traded up $1.63 during trading hours on Tuesday, reaching $81.43. 3,223,581 shares of the company's stock were exchanged, compared to its average volume of 3,437,852. The company has a quick ratio of 0.83, a current ratio of 1.06 and a debt-to-equity ratio of 1.11. The firm has a market capitalization of $37.17 billion, a price-to-earnings ratio of 23.68, a P/E/G ratio of 2.86 and a beta of 1.26. GE HealthCare Technologies Inc. has a 1-year low of $62.35 and a 1-year high of $94.50. The company has a 50-day moving average of $88.03 and a 200 day moving average of $79.18.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings results on Tuesday, April 30th. The company reported $0.90 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.90. The firm had revenue of $4.65 billion for the quarter, compared to analyst estimates of $4.80 billion. GE HealthCare Technologies had a return on equity of 25.32% and a net margin of 8.05%. The business's revenue was down 1.2% on a year-over-year basis. During the same quarter last year, the company posted $0.85 earnings per share. Research analysts anticipate that GE HealthCare Technologies Inc. will post 4.27 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be paid a dividend of $0.03 per share. This represents a $0.12 annualized dividend and a dividend yield of 0.15%. The ex-dividend date of this dividend is Thursday, April 18th. GE HealthCare Technologies's dividend payout ratio (DPR) is presently 3.51%.

Insider Buying and Selling

In other news, insider Frank R. Jimenez bought 1,315 shares of the stock in a transaction dated Wednesday, May 1st. The shares were acquired at an average price of $76.52 per share, with a total value of $100,623.80. Following the completion of the acquisition, the insider now directly owns 75,796 shares in the company, valued at $5,799,909.92. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.27% of the company's stock.

Wall Street Analyst Weigh In

Several research firms recently commented on GEHC. Argus increased their target price on GE HealthCare Technologies from $80.00 to $110.00 and gave the company a "buy" rating in a report on Monday, April 1st. Mizuho cut their target price on GE HealthCare Technologies from $110.00 to $105.00 and set a "buy" rating on the stock in a research report on Wednesday, May 1st. HSBC began coverage on GE HealthCare Technologies in a report on Thursday, February 15th. They issued a "buy" rating and a $100.00 price target for the company. Evercore ISI raised their price objective on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an "outperform" rating in a report on Thursday, April 4th. Finally, Citigroup upped their target price on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the company a "buy" rating in a report on Wednesday, April 3rd. Four investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $95.00.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.